Synthetic Genomics, Venter Institute Form Vaccines Firm | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and the non-profit J. Craig Venter Institute today announced that they have formed a new company, called Synthetic Genomics Vaccines, focused on genomic-based vaccines.

The partners, both based in La Jolla, Calif., and co-founded by Craig Venter, said they will develop next-generation vaccines using JCVI's genomic sequencing and synthetic genomic research expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.